More information available at:
- In 2014, change from three dose to two dose schedule for girls who started vaccination before age 14. for further information: http://www.ssi.dk/English/News/EPI-NEWS/2014/No%2028-32%20-%202014.aspx
- Babies born to a mother infected with hepatitis B will be offered a first vaccine dose at birth simultaneously with HepB immunoglobulin. Following vaccine doses are given at one month, 2 month and 12 month of age.
- For specific at risk-groups only
- PCV 13 also recommended.
For recommendations from Statens Serum Institut for vaccination of people within at-risk groups refer to http://www.ssi.dk/English/News/EPI-NEWS/2014/No%2040%20-%202014.aspx. There are no official recommendations from the Danish Health and Medicines Authority for use of PPV23 or PCV 13, but there is, however, reimbursement for defined at-risk groups.
- MMR vaccination possible from 9 months of age prior to visiting measles-endemic countries and areas where measles outbreaks are known to occur. The recommended two-dose vaccination schedule at 15 months and 4 years still need to be completed if first vaccination before 12 months.
- Gender-neutral vaccination offered since September 2019.
- Girls-only vaccination offered.
- for more information on the Danish influenza vaccination programme and vaccination of specific at-risk groups, please refer to http://www.ssi.dk/Vaccination/Influenzavaccination.aspx (in English)
MAJOR HISTORICAL CHANGES
1987: Two doses of MMR vaccination at 15 months and 12 years of age were introduced in the national childhood vaccination programme to children younger than 13 years of age  A one dose MMR catch up was offered for individuals born between 1974 and 1986. The overall uptake to this programme was poor.
1989: The two dose MMR vaccination schedule was extended to all those under 18 years 
2007: Introduction of PCV7 into national childhood vaccination programme as from 1st October 2007.
2008: From 1st April 2008 the second MMR dose is recommended to all children aged 4 years.  This replaced vaccination with the second MMR dose at 12 years of age. However, the second MMR dose will still be recommended to children aged 12 years in a catch-up programme that will last until 2016.
2008: Commencement of the HPV catch-up programme for girls born in 1993-95 on 1st October 2008. The offer ended 31 December 2010.
2009: Routine HPV vaccination programme for 12-year-old girls started on 1st January 2009. From this date onwards, the vaccination is free of charge for girls born in 1996 or later.
2010: Pneumococcal vaccination continued with PCV13 from 15th April 2010
2012: As from 1 April 2012, a temporary offer of free vaccination against measles, mumps and rubella (MMR) was implemented. The offer applies to young adults who have not had measles or previously have been vaccinated against measles. The offer comprises persons above 18 years of age born in 1974 or later and stayed in force until end of 2012. 
2012: As from 27 August 2012, a temporary offer of free HPV vaccination of adult women born between 1986 and 1992 has been put in place. The offer will stay in force until end of 2013 (5)
2014: Due to production problem at Statens Serum Institut a hexavalent DTaP-IPVHibHbv vaccine was used for primary vaccination of infants from January 2014. From January 2015 the normal pentavalent DTaP-IPVHib vaccine is in use. For further details consult http://www.ssi.dk/English/News/EPI-NEWS/2014/No%2050%20-%202014.aspx
SPECIFIC RECOMMENDATIONS FOR AT-RISK GROUPS:
- Healthcare workers: See the recent publication by Galanakis, E., F. D'Ancona, A. Jansen et al. The issue of mandatory vaccination for healthcare workers in Europe. Expert. Rev. Vaccines.2014. 13: 277-283.
- Women above 18 years of age who are not immune to rubella are offered MMR vaccination free of charge
1 Danish Ministry of the Interior, j.nr. 4.s.k.t. 5320-24/1986. 11 February 1986
2 Danish Ministry of Health, j.nr. 5.k.t. 630-5/1989. 15 December 1989
3 MMR 2 vaccination advanced to 4 years. S. Glismann, A. H. Christiansen. EPI-NEWS 2008; 9. Also accessible on-line at Statens Serum Institut website: in English and in Danish.
4. SSI EPI News n.12 - 2012 available at http://www.ssi.dk/English/News/EPI-NEWS/2012/No%2012%20-%202012.aspx
5. SSI EPI-NEWS n. 28/33 – 2012 avaialable at http://www.ssi.dk/English/News/EPI-NEWS/2012/No%2028-33%20-%202012.aspx
Date of last update: 10 July 2017